An enzyme that usually stops bacterial growth in the large intestine stimulates inflammation in some people, resulting in ulcerative colitis—a chronic digestive disease that affects more than 750,000 Americans, according ...
Aug 18, 2020
0
65
Antibiotics use, particularly antibiotics with greater spectrum of microbial coverage, may be associated with an increased risk of new-onset inflammatory bowel disease (IBD) and its subtypes ulcerative colitis and Crohn's ...
Aug 17, 2020
1
80
A new study has found one in ten people with inflammatory bowel disease visited their doctor with symptoms five years before receiving a diagnosis.
Aug 10, 2020
0
48
In a world first, Monash University researchers have identified a key biomolecule that enhances the repair of your gut lining by prompting stem cells to regenerate damaged tissue.
Jul 20, 2020
2
585
Finding the right treatment for people living with chronic intestinal inflammation, also known as inflammatory bowel disease (IBD), might soon be getting easier. World IBD Day happens on 19 May each year, with the goal to ...
Jul 7, 2020
0
2
Investigators at APC Microbiome Ireland SFI Research Center in Cork were stunned by the findings of the first microbiome study of Irish Travelers which challenges the concept of a "normal" or "healthy" microbiome and asks: ...
Jul 7, 2020
0
131
According to findings published this week in mBio, Nissle, a strain of Escherichia coli, is harmless to intestinal tissue and may protect the gut from enterohemorrhagic E. coli, a pathogen that produces Shiga toxin.
Jul 7, 2020
0
3
Inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, is linked to a more than doubling in the risk of developing dementia, finds research published online in the journal Gut.
Jun 23, 2020
0
73
New research indicates that taking vitamin D supplements may help prevent a potentially serious side effect of a revolutionary form of anti-cancer therapy. The findings are published early online in Cancer, a peer-reviewed ...
Jun 22, 2020
0
91
Biologics to modulate the migration and activation of specific innate immune cells, called neutrophils, discovered in the lab of Beth McCormick, Ph.D., at UMass Medical School, have been licensed by Bacainn Therapeutics, ...
Jun 17, 2020
0
2
